INTRODUCTION: Normal tissue homeostasis requires a precise maintenance of balance between angiogenic inducers and inhibitors. Thrombospondins-1 and-2 are highly regulated matricellular proteins that have been shown to function in vivo to inhibit angiogenesis in multiple conditions, including the cutaneous wound healing response and in some tumor beds. Our lab, in collaboration with Bouck and colleagues1,2, identifie
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondin-l (TSPl) is a multidomain glycoprotein expressed by many cell types. It is a multifun...
<div><p>The angiogenic switch is a promising therapeutic target in cancer. Work by our laboratory an...
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer....
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer....
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer...
Thrombospondins (TSPs) are a family of extracellular matrix proteins that regulate tissue genesis an...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Angiogenesis, de novo synthesis of blood vessels from the pre-existing vasculature, is required both...
Histidine-rich glycoprotein (HRG) is a heparin-binding plasma protein modulating immune, hemostatic ...
Histidine-rich glycoprotein (HRG) is a heparin-binding plasma protein modulating immune, hemostatic ...
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondin-l (TSPl) is a multidomain glycoprotein expressed by many cell types. It is a multifun...
<div><p>The angiogenic switch is a promising therapeutic target in cancer. Work by our laboratory an...
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer....
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer....
Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer...
Thrombospondins (TSPs) are a family of extracellular matrix proteins that regulate tissue genesis an...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality in the developed wo...
Angiogenesis, de novo synthesis of blood vessels from the pre-existing vasculature, is required both...
Histidine-rich glycoprotein (HRG) is a heparin-binding plasma protein modulating immune, hemostatic ...
Histidine-rich glycoprotein (HRG) is a heparin-binding plasma protein modulating immune, hemostatic ...
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondins TSP-1 and TSP-2 are potent endogenous inhibitors of angiogenesis. They inhibit angio...
Thrombospondin-l (TSPl) is a multidomain glycoprotein expressed by many cell types. It is a multifun...